Success Metrics

Clinical Success Rate

50.0%

Based on 1 completed trials

Completion Rate

50%(1/2)

Active Trials

1(20%)

Results Posted

0%(0 trials)

Terminated

1(20%)

Phase Distribution

Ph phase_2

20%

Ph not_applicable

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

Phase 2Efficacy & side effects

1(50.0%)

N/ANon-phased studies

1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Terminated(2)

Other(1)

Detailed Status

Terminated1

Withdrawn1

Completed1

Active, not recruiting1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (50.0%)

N/A1 (50.0%)

Trials by Status

terminated120%

withdrawn120%

completed120%

active_not_recruiting120%

unknown120%

Recent Activity

1 active trials

Showing 5 of 5

terminated

Physical Activity and People Living With HIV in New York City

NCT07091253

withdrawnphase_2

SARS-CoV-2 Safety Study for the Treatment of COVID-19

NCT06489860

active_not_recruiting

The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT Study

NCT04087239

unknown

Effects of COVID-19 on Endothelium in HIV-Positive Patients in Sub-Saharan Africa

NCT04709302

completednot_applicable

Development and Piloting of a Just-in-Time, Personalized HIV Prevention Intervention for Youth Experiencing Homelessness and Unstable Housing

NCT03911024

Clinical Trials (5)

Showing 5 of 5 trials

NCT07091253

Physical Activity and People Living With HIV in New York City

Terminated

NCT06489860Phase 2

SARS-CoV-2 Safety Study for the Treatment of COVID-19

Withdrawn

NCT04087239

The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT Study

Active Not Recruiting

NCT04709302

Effects of COVID-19 on Endothelium in HIV-Positive Patients in Sub-Saharan Africa

Unknown

NCT03911024Not Applicable

Development and Piloting of a Just-in-Time, Personalized HIV Prevention Intervention for Youth Experiencing Homelessness and Unstable Housing

Completed

All 5 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 5